Table 7 —
Author(s) (year) | No. of eyes (# subjects) | Device | Impaired visual field parameters (compared to the control group) | ||
---|---|---|---|---|---|
No DR | NPDR | PDR | |||
Joltikov et al (2017)81 | CN = 18 (n = 18) No DR = 23 (n = 23) Mild NPDR = 19 (n = 19) Moderate NPDR = 15 (n = 15) |
FDP 24–2 and 10–2 strategy | None | FDP 24–2: ↑ PSD ↓ MD FDP 10–2: ↓ MD | |
Stem et al (2016)137 | CN = 23 (n = 23) No DR = 16 (n = 16) NPDR = 14 (n = 14): 11 Mild and 3 Moderate NPDR. |
FDP 24–2 strategy | None | ↓ MD | |
Boynton et al (2015)27 | CN = 15 (n = 15) No PRP = 15 (n = 15) PRP = 30 (n = 30) |
FDP 24–2 strategy | ↑ PSD ↓ MD ↓ Foveal Sensitivity | ||
Pinilla et al (2013)112 | CN = 30 (n = 30) No DR = 55 (n = 55) Mild NPDR = 18 (n = 18) |
FDT C-20 strategy | ↑ PSD | ||
Jackson et al (2012)77 | CN = 18 (n = 18) No DR = 23 (n = 23) NPDR = 35 (n = 35) |
FDP 24–2 strategy | ↓ Mean Foveal Sensitivity | ↓ Mean Foveal Sensitivity | |
Parravano et al (2008)110 | CN = 30 (n = 30) No DR = 30 (n = 30) |
FDT 30–2 strategy | ↓ MD |
CN, control; DR, diabetic retinopathy; NPDR, nonproliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy; PRP, pan-retinal photocoagulation.